VCEL Similar Chart Price Prediction
The price of VCEL is predicted to go up -6.15%, based on the high correlation periods with SGMA. The similarity of these two price pattern on the periods is 95.9%.
VCEL
SGMA
Down: -6.15%Similarity: 95.9%
VCEL Revenue Forecast
VCEL EPS Forecast
VCEL FAQs
What is bull’s view on VCEL?
What is bear's view on VCEL?
What is VCEL revenue forecast for next quarter？
What is VCEL eps forecast for next quarter？
VCEL Analyst's Forecast
Samuel Brodovsky
Truist Securities
Strong Buy
2024-12-18
Price Target
$61 → $67
Upside
+19.11%
Truist analyst Richard Newitter raised the firm's price target on Vericel to $67 from $61 and keeps a Buy rating on the shares as part of a broader research note previewing 2025 in Medical Technology. The firm sees the sector as "one of the better/safer houses" in healthcare given its lower "front-line" exposure to healthcare policy rhetoric that is tied to the administration change as well as its position as an "innovation segment" with sustainable above-average revenue and EPS growth, strong balance sheets, and healthy free cash flows. Truist adds that it prefers small-mid size companies over large caps as M&A may be "poised to heat up".
Ryan Zimmerman
BTIG
Strong Buy
2024-11-26
Price Target
$56 → $66
Upside
+12.34%
